Journal article
Expression of myostatin in intrauterine growth restriction and preeclampsia complicated pregnancies and alterations to cytokine production by first-trimester placental explants following myostatin treatment
HN Peiris, H Georgiou, M Lappas, T Kaitu'U-Lino, C Salomón, K Vaswani, GE Rice, MD Mitchell
Reproductive Sciences | SAGE PUBLICATIONS INC | Published : 2015
Abstract
Preeclampsia (PE) and intrauterine growth restriction (IUGR) are major obstetric health problems. Higher levels of T-helper (Th) 1 (proinflammatory) cytokines have been observed in pregnancies complicated with PE and IUGR; this is in contrast to the predominant Th2 (anti-inflammatory) cytokine environment found in uncomplicated pregnancies. Myostatin is best known as a negative regulator of muscle development and reportedly has a role in fat deposition, glucose metabolism, and cytokine modulation (outside the placenta). Myostatin concentrations in plasma and protein expression in placental tissue are significantly higher in women with PE. Expression of myostatin in IUGR and PE-IUGR and the e..
View full abstractRelated Projects (1)
Grants
Awarded by Diabetes Australia Research Trust
Funding Acknowledgements
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by funding from the Diabetes Australia Research Trust (Y13G-MITM) and Therapeutic Innovation Australia. Associate Professor Martha Lappas is supported by a Career Development Fellowship by the National Health and Medical Research Council (NHMRC; grant no. 1047025).